Pj. Vandiest et al., CYCLIN D1 EXPRESSION IN INVASIVE BREAST-CANCER - CORRELATIONS AND PROGNOSTIC VALUE, The American journal of pathology, 150(2), 1997, pp. 705-711
Cyclin D1 overexpression, detected by standard immunohistochemistry, w
as correlated with other prognostic variables and ifs prognostic value
teas evaluated in a group of 148 invasive breast cancers with long-te
rm follow-up. Overexpression of cyclin D1 (53% of cases) was negativel
y correlated (chi(2) test) with histological grade (P = 0.0001), mean
nuclear area (P = 0.004), mean nuclear volume (P = 0.02), and mitotic
activity (P = 0.03) and positively correlated with estrogen receptor (
P = 0.0001), There was a strong correlation between cyclin DI overexpr
ession and histological type (P = 0.0001), Positive cyclin D1 staining
was seen in 11 of 13 tubular carcinomas, 3 of 3 mucinous carcinomas,
4 of 4 invasive cribriform carcinomas, and 17 of 20 lobular carcinomas
, Of 102 ductal cancers, 52 were positive, and all 6 medullary carcino
mas were negative. There were no significant correlations with lymph n
one status, tumor size, or DNA ploidy, In survival analysis, cyclin D1
overexpression did not provide significant univariate or multivaraiat
e prognostic value In conclusion, cyclin D1 is mainly overexpressed in
the well differentiated and lobular types of invasive breast cancer a
nd is strongly associated with estrogen receptor positivity. If is neg
atively correlated with the proliferation marker mitoses count and wit
h the differentiation marker nuclear area and nuclear volume. However,
cyclin D1 overexpression does not seem to have prognostic value in in
vasive breast cancer when no adjuvant treatment is given.